Abdel-Magid AF. Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors as Potential Treatment for Several Inflammatory and Neurodegenerative Diseases. ACS Med Chem Lett. 2025 Feb 13;16(2):204-206. Epub 2025 Jan 27 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.